Humira® Now approved for Psoriatic Arthritis
Cranberry Township, PA, December 5, 2005
HUMIRA® is approved for reducing the signs and symptoms, inducing major clinical response, slowing the progression of joint damage, and improving physical function in adult patients with moderate to severe rheumatoid arthritis. HUMIRA is also approved for reducing the signs and symptoms of active arthritis in patients with psoriatic arthritis. HUMIRA can be used alone or with methotrexate or other DMARDs (disease modifying anti-rheumatic drugs).
For more information go to www.humira.com